Dr. Genevieve L. Egnatios, MD

Dr. Egnatios practices at Health360 LLC in Scottsdale, Arizona.

Dr. Egnatios' NPI, 1164683793, was assigned on June 17, 2008. Dr. Egnatios graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2008. Dr. Egnatios holds Arizona license 42177.

Dr. Egnatios' primary practice is Health360 LLC, at 11333 N Scottsdale Rd, Scottsdale, AZ 85254 in Maricopa County. The practice phone is (480) 765-2800.

Dr. Egnatios' primary practice is Health360 LLC in Scottsdale, Arizona. The medical group on file is Scottsdale Skin Boutique & Dermatology. Dmand AI also links Dr. Egnatios to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Egnatios practices. Vendor and product names are available with a free account.

Dermatology is Dr. Egnatios' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Egnatios is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Egnatios' licenses on file in 2 states: Arizona and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Egnatios treats.

CMS data shows 9,708 Medicare services from Dr. Egnatios across 34 procedure codes in 2024, for 609 Medicare patients. Medicare paid $730,655 for them. Every service was in an office.

CMS counts 609 Medicare patients who saw Dr. Egnatios in 2024. The largest group is 65 to 74, with 297 patients. 75% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Egnatios' median patient age at 71, with 59% women.

In 2024, Dr. Egnatios wrote 903 Medicare Part D claims for 307 patients. 98% of them were for generic drugs. CMS names the drug for 795 of them, across 16 drugs with 11 or more claims each, at $17,682 in total drug cost. In 2023, CMS named 548 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Egnatios for performance year 2024, reported as part of a group. Dr. Egnatios accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 656 procedures of skin biopsy by Dr. Egnatios, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Egnatios. The most frequent topics are Skin and Skin Neoplasms. Dr. Egnatios' most frequent co-authors are Ryan Francis Andrulonis, MD, Howard B. Pride, MD and Molly Mae Warthan, MD.

CMS Open Payments shows 248 general payments to Dr. Egnatios from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $1,219.

Dr. Egnatios graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2008.

Dr. Egnatios is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.